Pinsent Masons continues its expansion in Dublin office

15 Jul 2019 | 11:23 am | 1 min. read

Pinsent Masons continues its expansion in Dublin office with Life Sciences and Technology Litigation hire

International law firm Pinsent Masons has boosted its pan European life sciences and technology sector capabilities with the appointment of Michael Finn as partner in its Dublin office.


Michael will be joining from Matheson, where he leads its IP disputes group and previously established its life sciences regulatory and litigation practice.

 

 Michael advises on complex domestic and international commercial disputes, contentious intellectual property matters, data privacy disputes, regulatory matters including prosecutions, product liability, and judicial review. He has extensive experience in large-scale litigation before the Irish Commercial Court.

 

 A valuable addition to the Dublin IP and data team, he will work alongside IP and data litigation specialist Ann Henry to enhance the firm's Big Pharma offering in Dublin.

 

Clare Tunstall, Head of Life Sciences at Pinsent Masons said:

 "We are continuing to invest in appointing talented individuals who bolster our ability to service our international client base. Pinsent Masons has a pan European team of lawyers specialising in Life Sciences & Healthcare who advise across a range of IP, transactional and regulatory matters and Michael's stellar reputation and experience makes him a fantastic addition to our team."

 

During his career, Michael has acted for some of the largest organisations in the Life Sciences and technology sectors. His work includes advising technology companies on the convergence of tech, life sciences and medical device laws. He has acted in IP litigation for some of the world’s best known technology brands, and has advised one of the world’s largest life sciences companies in the defence of product liability litigation relating to a market-leading immunology product. 

 

 Gayle Bowen, Head of Pinsent Masons' Dublin office adds:

 "Michael is a recognised leading practitioner who brings sector knowledge and expertise that is unmatched in the Irish market. His diverse experience complements Pinsent Masons' international Advanced Manufacturing and Technology sector and is a valuable addition to our Dublin office."

 

 Michael's appointment continues the expansion of Pinsent Masons' Dublin office, and follows the firm's recent recruitment of Corporate Financial Services partner Naoise Harnett.

 

 In May, the firm also announced the appointment of Robert Vidal to its London office, enhancing its competition law expertise within the life sciences sector.

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile
Gayle Bowen

Gayle Bowen

Partner, Head of Office, Dublin

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

Pinsent Masons advises on commercial close of four new dialysis clinics in Uzbekistan

Multinational law firm Pinsent Masons has advised on the commercial close of four dialysis centres – a pathfinder public private partnership (PPP) implemented in Uzbekistan.

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts